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ABSTRACT
DNA2 nuclease/helicase is a structure-specific nu-
clease, 5′-to-3′ helicase, and DNA-dependent AT-
Pase. It is involved in multiple DNA metabolic path-
ways, including Okazaki fragment maturation, repli-
cation of ‘difficult-to-replicate’ DNA regions, end re-
section, stalled replication fork processing, and mi-
tochondrial genome maintenance. The participation
of DNA2 in these different pathways is regulated by
its interactions with distinct groups of DNA repli-
cation and repair proteins and by post-translational
modifications. These regulatory mechanisms induce
its recruitment to specific DNA replication or repair
complexes, such as DNA replication and end resec-
tion machinery, and stimulate its efficient cleavage
of various structures, for example, to remove RNA
primers or to produce 3′ overhangs at telomeres or
double-strand breaks. Through these versatile ac-
tivities at replication forks and DNA damage sites,
DNA2 functions as both a tumor suppressor and pro-
moter. In normal cells, it suppresses tumorigenesis
by maintaining the genomic integrity. Thus, DNA2
mutations or functional deficiency may lead to can-
cer initiation. However, DNA2 may also function as a
tumor promoter, supporting cancer cell survival by
counteracting replication stress. Therefore, it may
serve as an ideal target to sensitize advanced DNA2-
overexpressing cancers to current chemo- and radio-
therapy regimens.
INTRODUCTION
Maintaining the integrity of the genome depends on faith-
ful DNA replication and proper repair of DNA damage.
Various DNA intermediates are formed during these DNA
metabolic processes, and they must be efficiently and prop-
erly processed to avoid severe genomic instability. The most
frequently occurring intermediates are Okazaki fragments,
which are formed during lagging strand DNA synthesis (1).
It is estimated that millions of Okazaki fragments are gen-
erated per mammalian cell cycle (2). Each Okazaki frag-
ment contains an RNA–DNA primer, synthesized by the
Pol  (DNA polymerase subunit alpha)/primase complex,
at its 5′ end. The RNA portion of the primer must be
removed so that the Okazaki fragments can be joined to
form intact lagging strand DNA (2). In the case that Pol
 introduces errors, the Pol  synthesized DNA may be
removed via nucleotytic editing mechanisms before join-
ing (2). Meanwhile, DNA molecules frequently encounter
DNA-damaging insults that cause various lesions, includ-
ing base damage, inter-strand cross-links, DNA single-
strand breaks (SSBs) and double-strand breaks (DSBs).
Such DNA lesions and the intermediates that form dur-
ing their metabolism must be repaired to avoid DNA mu-
tations, deletions, insertions and translocations (3). For ex-
ample, other commonly generated replication intermediates
are stalled replication forks, which can arise due to both en-
dogenous or exogenous replication barriers, such as stable
secondary structures on the DNA template, protein–DNA
complexes and DNA lesions (4–6). Stalled replication forks
may be transformed into regressed forks to promote fork
restart; however, these structures are potentially deleterious
and must be properly processed to restart DNA replication
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without introducing errors (4). Specific nuclease and heli-
case complexes recognize and are required to process differ-
ent subsets of DNA intermediates, including Okazaki frag-
ments and stalled replication forks. Helicases can unwind
and transform the intermediates, whereas nuclease com-
plexes cleave phosphodiester bonds, independent of DNA
sequence, to ultimately produce DNA structures appropri-
ate for ligation, continuous DNA replication or recombina-
tion.
DNA2 nuclease/helicase, an enzyme conserved in eu-
karyotic organisms, is critical for the metabolism of several
DNA intermediates (Table 1). DNA2 was originally discov-
ered through the characterization of a temperature-sensitive
and DNA replication-defective mutant strain of Saccha-
romyces cerevisiae (yeast), namely the dna2 mutant strain
(7). Saccharomyces cerevisiae dna2 mutants also emerged
in a genetic screen for strains that require overexpres-
sion of the protein kinase Tor1p for viability (8) and as
a gene synthetic lethal with ctf4 mutations (9). The S.
cerevisiae DNA2 (scDNA2) gene encodes a 172-kD (1522-
amino acid) protein, which has nuclease, 5′-to-3′ DNA he-
licase, and DNA-dependent ATPase activities. It has a PD-
(D/E)XK nuclease superfamily motif at its center and an
ATP-dependent SF1B helicase family motor domain at its
C-terminus (7,10). Additional studies also identified a regu-
latoryN-terminal domain (11,12) that interacts with the nu-
clease domain and inhibits its endonuclease activity. Thus,
the removal of this regulatory domain using proteolysis
greatly stimulates the nuclease activity of scDNA2. In ad-
dition, an iron–sulfur (Fe–S) cluster motif was identified
within the nuclease domain of scDNA2 (13). Surprisingly,
mutations that disrupt the Fe–S cluster motif abolish not
only the nuclease but also the helicase activities of scDNA2,
suggesting that the Fe–S cluster plays a role in coupling
them (13). The scDNA2 protein also has three types of clas-
sical nuclear localization signals (NLSs) that direct its mi-
gration into the nucleus (14).
scDNA2 orthologs were subsequently identified in
Schizosaccharomes pombe (fission yeast) (15), Caenorhab-
ditis elegans (16), Xenopus laevis (17) and mammals (18–
20). Like scDNA2, they all have a core nuclease domain,
ATPase/helicase domains, and an Fe–S cluster motif. Inter-
estingly, throughout evolution, DNA2 proteins have gradu-
ally lost NLSs (14). Whereas Dna2 proteins in single-cell
organisms, such as S. cerevisiae and S. pombe, have all
three types of classical NLSs, their orthologs in Arabidop-
sis, C. elegans, Drosophila, puffer fish, and frogs, have only
one or two types of NLSs, and vertebrate DNA2 proteins
lack all three. Furthermore, mammalian DNA2 lacks the
amino acids found in the N-terminal regulatory domain
of scDNA2. These findings suggest that, although eukary-
otic DNA2 proteins have similar functions in DNA replica-
tion and repair, themechanisms regulating them likely differ
across organisms.
The participation of DNA2 in various DNA metabolic
pathways is controlled by several factors. Many DNA repli-
cation and repair proteins, as well as post-translational
modifications of DNA2, have been found to stimulate its
ability to efficiently resect DNA ends, degrade regressing or
regressed forks, or cleave DNA flaps. These activities are
necessary to promote genome integrity in normal cells, as
functional deficiency of DNA2 has been shown to cause
genome instability and promote cancer initiation in mam-
mals (21). Thus, DNA2 is considered to be a tumor sup-
pressor. However, some DNA2 interaction partners are re-
quired to inhibit its activity to avoid the deleterious effects
of its uncontrolled action on DNA intermediates. For in-
stance, over-resection of stalled or regressed fork structures
by DNA2 may cause fork collapse, increasing genome in-
stability (22). Furthermore, DNA2 is overexpressed in sev-
eral human cancers and has been found to support cancer
cell survival by counteractingDNA replication stresses (23).
Therefore, DNA2 may serve as a target for killing cancer
cells or sensitizing cancer cells to existing chemotherapeu-
tic agents.
ENZYMATIC ACTIVITIES OF DNA2
Various biochemical characterizations of DNA2 proteins
from different model organisms have shown that DNA2
possesses structure-specific nuclease, helicase and ATPase
activities (7,10,15–17,19,20,24,25). It is now also com-
monly accepted that the DNA-dependent ATPase domain
of DNA2, probably in coordination with its nuclease do-
main, functions as an ssDNA translocase in end resec-
tion during DSB repair (26,27). The enzyme activities of
DNA2 require the presence of divalent cations, but the opti-
mal concentrations required vary for each activity (e.g. 2.5–
10.0 mM of Mg2+ for optimal nuclease activity, 1–2 mM
for optimal helicase activity and 0.15–0.30 mM for opti-
mal ATPase activity) (7,28). DNA2 also requires an intact
Fe–S cluster to support both its nuclease and ATPase mo-
tor activities (13). In addition, its helicase and nuclease ac-
tivities are modulated by ATP, as high (≥2 mM) concen-
trations of ATP reduce its nuclease activity, which likely
causes the stimulation of its helicase activity (28,29). In-
deed, robust helicase activity is only observed when the
nuclease is attenuated by mutations or by high levels of
ATP (7,30). Nevertheless, these observations do not rule
out a role for the helicase in other processes mediated by
DNA2 (31).
The DNA2 nuclease preferentially cleaves ssDNA from
either a 5′ or 3′ end, but it can also cleave the ssDNA strand
within a 5′ flap structure. The 5′ nuclease activity of DNA2
can be blocked by either an annealed oligonucleotide or
a streptavidin–biotin conjugate at the 5′ terminus, demon-
strating that, like flap endonuclease 1 (FEN1), DNA2 re-
quires a free 5′ end (32). Unlike FEN1, however, DNA2 can
also be blocked by a branch in the flap, indicating that it
may also use a threading mechanism and track on ssDNA
to reach the point of cleavage (32). The DNA2 helicase can
unwind DNA duplexes to generate ssDNA regions (7,30),
but unlike other known helicases, it requires the presence
of a single-stranded 5′ end adjacent to the double-stranded
DNA (dsDNA) to be unwound (33). Indeed, a detailed
study of DNA2–DNA binding showed that DNA2 binds
preferentially to the junction between ssDNA and duplex
DNA. DNase1 footprinting revealed that DNA2 protects
both the ssDNA, as well as the junction between the ssDNA
and dsDNA (i.e. the base of the flap) (34).
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Table 1. Summary of DNA2 substrates and activities in various pathways across organisms
Crystal structures of full-length mouse DNA2 in com-
plex with a 15-nt ssDNA oligonucleotide illustrate, in part,
how DNA2 recognizes and cleaves its DNA substrate (35).
The DNA2-ssDNA complex displays an overall cylindrical
shape with a long, narrow central tunnel (Figure 1). The
nuclease domain is at the base of the cylinder; a -barrel
motif and stalk, as well as the helicase 1A domain, are on
the top of the nuclease domain; and the helicase 2A domain
is at the top of the cylinder. Because only ssDNA was in
the structure, the binding site for dsDNA was not revealed;
however, in keeping with the DNase I footprinting stud-
ies, it is predicted to be at the base of the nuclease domain
(34). The nuclease active center and the DNA-binding mo-
tifs of the nuclease and helicase domains are enclosed in the
central tunnel. The narrow tunnel allows only ssDNA to
thread through, with the 5′ end of the ssDNA positioned
at the DNA-binding motifs of the motor domain and the 3′
end positioned at the nuclease domain (35). These structural
limitations explain why DNA2 preferentially acts on DNA
substrates with free ssDNA ends and without branches or
secondary structures (7,32,34).
FUNCTIONAL ANALYSES OF DNA2 BASED ON CEL-
LULAR PATHWAYS
Okazaki fragment maturation
The synthesis of Okazaki fragments on the lagging strand
DNA template is initiated by the Pol /primase complex,
which synthesizes RNA–DNA primers. The primers con-
sist of a RNA (7–14 nt) followed by a short stretch (10–
20 nt) of DNA (36,37). The RNA-DNA primers are ex-
tended by Pol  (DNA polymerase delta) in a series of
discrete Okazaki fragments, which are about 200 nt in
length (38–41). Through strand displacement, Pol  creates
RNA–DNAflaps thatmust be endonucleolytically removed
(42,43) so that the Okazaki fragments can be joined into an
intact laggingDNA strand. In the case that Pol incorpora-
tion errors are introduced, the Pol -synthesized DNA por-
tionmay be via the long flap cleavage or theFEN1-mediated
error editing mechanisms (2).
Several different pathways contribute to flap removal and
ligation. Most flaps are removed by FEN1 (2,41,44,45);
however, the genetic and physical interactions between
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Figure 1. Schematic of the DNA2–DNA complex, elucidating its overall
structure and the proposed mechanism for substrate binding and cleavage.
Mouse DNA2 has an overall cylindrical shape. A narrow central tunnel
is formed within the nuclease domain at the base and is extended by a -
barrel motif and a helicase 1A domain in the middle. A helicase 2A do-
main sits atop the tunnel. Several residues important for DNA substrate
binding are indicated along the tunnel. The central tunnel is too narrow
to allow dsDNA to access the active center in the nuclease domain. How-
ever, ssDNA can enter the tunnel through the bottom or top and thread
to the other side. This schematic is based on previously published crystal
structure information (35), with the two Ca2+ ions in the crystal structure
replaced by two Mg2+ ions to reflect the role of Mg2+ as a co-factor for
DNA2 catalysis.
scDNA2 and scFEN1 (Rad27) suggested that DNA2 also
plays a role in flap removal during Okazaki fragment matu-
ration (46). This hypothesis was supported by the observa-
tion that DNA synthesized in a temperature-sensitive dna2
mutant was shorter than full-length (7). Mutations in the
scDNA2 nuclease active site revealed that its nuclease ac-
tivity is necessary for the essential functions of scDNA2
in DNA replication (10,47). However, the helicase activ-
ity of DNA2, which is crucial for DNA replication in vivo
(7,48), was thought to facilitate formation of short DNA
flaps for removal (10,24,49). In addition, scDNA2 helicase
activity was shown to resolve secondary structures to fa-
cilitate the scFEN1-mediated cleavage of RNA-DNA flaps
(49). Nevertheless, scDNA2 helicase activity was proven to
be dispensable for yeast chromosomal DNA replication,
though growth is inhibited in its absence and it is required
for repair of methyl methanesulfonate-induced DNA dam-
age (9,49,50).
These observations ultimately gave rise to amodel that in-
tegratesmultiple pathways of Okazaki fragment processing,
each of which consists of 5′ flap structure removal before
ligation. In one pathway, when an active Pol /PCNA com-
plex encounters the RNA-DNA primer of the downstream
Okazaki fragment, it displaces a short segment of a single-
stranded RNA (ssRNA)-DNA flap of 2–10 nt (2), which is
removed by FEN1 in a nick-translation reaction until the
RNA segment is removed and a ligatable nick is available.
If FEN1 is compromised, another structure-specific nucle-
ase, exonuclease 1 (EXO1), can partially compensate by re-
moving short flaps. In addition, it was proposed that Pol
/PCNAcan also give rise to long flaps and that both FEN1
and DNA2 could function in long flap removal. However,
long flaps can be bound by replication protein-A complex
(RPA), which inhibits FEN1 (11). Thus, in the presence of
RPA, FEN1 alone can remove short flaps of less than 10 nt
but not flaps longer than 30 nt (11,51,52). Interestingly, un-
der conditions in which the scDNA2 helicase was active, the
presence of scDNA2 stimulated scFEN1 to cleave longer
flaps (11), even when they contained CTG fold-back sec-
ondary structures (52). This model suggested that FEN1
acts on most Okazaki fragments, but DNA2 is required for
cleaving long flaps and flaps with secondary structures. In
fact, the situation is even more complex. Further analysis
revealed that DNA2 and FEN1 act sequentially in the long-
flap pathway (Figure 2). First, DNA2 is recruited by RPA
to static long-flap substrates. After it displaces the RPA, it
tracks along and cleaves the flap to 5–7 nt, reducing its affin-
ity for RPA. FEN1 then displaces DNA2, tracks along the
remaining short flap, and cleaves at the base of the flap, cre-
ating a ligatable nick (11,53,54).
The physiological significance of the long-flap pathway
remained unknown but was partially addressed by the iden-
tification of a new pathway component: PIF1 helicase.
scDNA2 was known to function at telomeres, as was PIF1
(50,55). During genetic studies of epistasis between DNA2
and other telomeric proteins, it was found that deletion of
PIF1 (pif1Δ) suppressed the lethality of nuclease-dead dna2
mutants and even of complete DNA2 gene deletion in S.
cerevisiae (56). In S. pombe, a temperature-sensitive muta-
tion of pfh1 (which encodes Pif1) also suppressed the loss-
of-function phenotype in a dna2 mutant with temperature-
sensitive mutations in the helicase domain (57,58). Thus,
whereas the scDNA2 nuclease is essential in normal yeast
cells, it is dispensable in the absence of PIF1 helicase. To
explain this phenomenon, it was proposed that PIF1 asso-
ciates with Pol  to processively displace RNA–DNA flaps,
which require the long-flap pathway for processing (Figure
2). Indeed, using a substrate that contained a circular DNA
template with an upstream oligonucleotide primer sepa-
rated by a gap from a downstream oligonucleotide, it was
demonstrated that Pif1 and Pol /PCNA generated long
flaps that required both DNA2 and FEN1 to produce lig-
atable nicks (42,59,60). In addition, it had previously been
shown that scFEN1 inefficiently cleaves short flaps (61), and
even in the absence of long flaps, the long-flap pathway
proteins (PIF1, RPA and scDNA2) were shown to stimu-
late the FEN1-mediated short-flap pathway (62). Thus, the
long-flap pathway proteins contribute to the flexibility of
Okazaki fragment processing in at least two ways: (i) pro-
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Figure 2. Sequential actions of DNA2 and FEN1 to remove a long RNA–
DNA flap during Okazaki fragment maturation. RPA binds to long 5′
RNA-DNA flaps generated by Pol /PCNA and/or PIF1. The flap-bound
RPA inhibits the action of FEN1 on the flaps and simultaneously recruits
and stimulates DNA2 to cleave at the middle of the ssDNA strand, gen-
erating a shorter (∼8 nt) 5′ flap. FEN1 then dislodges DNA2 and cleaves
at the junction between the ssDNA and dsDNA strands. DNA2 can also
function alone to process long flaps. The RPA-mediated sequential actions
of DNA2 and FEN1 or of DNA2 alone produce ligatable DNA nicks that
can be joined to form intact lagging strand DNA.
cessing long flaps and (ii) stimulating the short-flap path-
way. In addition, several studies have also suggested the ex-
istence of a long-flap pathway in which DNA2 functions
alone, without FEN1 (63,64).
The potential toxicity of long flaps raises a fundamen-
tal question: What accounts for the evolution and reten-
tion of long flap production and processing? One interest-
ing proposal is that DNA2, in order to facilitate the replica-
tion of difficult templates, has ‘hi-jacked’ the break-induced
replication (BIR) process, in which PIF1 facilitates strand
displacement by Pol  to produce migrating bubble struc-
tures through which DNA synthesis can proceed (65–67).
However, Okazaki fragment processing is more important
than BIR for cell viability, so it is more likely that that
PIF1 evolved to play an essential role in generating ligat-
able Okazaki fragments. This model posits that the hun-
dreds of thousands of Okazaki fragments in yeast, as well
as the millions in metazoans, render inevitable the stochas-
tic failure of FEN1, necessitating the existence of efficient
backup pathways. EXO1 provides a backup for short flap
processing, but S. cerevisiae exo1 rad27 double mutants are
viable, suggesting that an additional pathway exists. This es-
sential failsafe is DNA2. However, DNA2 cannot act on
short flaps. Thus, the role of PIF1 is likely to provide an
opportunity for DNA2 to participate in Okazaki fragment
processing by creating long flaps that can recruit DNA2
for efficient cleavage. In the absence of PIF1, DNA2 can-
not backup FEN1. In keeping with this, whereas pif1Δ sup-
presses the lethality of DNA2 loss, it causes synthetic sick-
ness with rad27Δ and synthetic lethalitywith rad27Δ exo1Δ
(68). In addition, pif1Δ dna2Δ is synthetically lethal with
deletions of genes encoding RNAse H2 subunits, rnh202Δ
and rnh35Δ, suggesting that an RNAse H/FEN1 pathway
may come into play when DNA2 cannot be recruited to
long flaps (44,69). Finally, pif1Δ may not be lethal due to
backup provided by helicase Rrm3. In S. pombe, which
lacks RRM3, PIF1 is essential. In Okazaki fragment pro-
cessing, therefore, there are many ways to ‘skin the cat.’
The PIF1 studies provided the first formal, albeit indi-
rect, evidence for the accumulation of long-flap Okazaki
fragment intermediates in vivo in the absence of scDNA2.
When PIF1 was intact in dna2 mutants, the S phase check-
point, which can be triggered by the ssDNA-binding pro-
tein RPA, was strongly induced; however, deletion of PIF1
or POL32, which encodes the processivity subunit of Pol
, prevented checkpoint activation (56,65). This suggested
that, upon loss of scDNA2 alone, long flaps accumulated
in numbers sufficient to bind enough RPA to induce the
DNA replication checkpoint. Interestingly, deletion of the
checkpoint mediators RAD9 and MRC1 also suppressed
lethality in dna2mutant yeast, suggesting that the scDNA2-
deficient cells were killed due to checkpoint induction by
immature Okazaki fragments (8,9,65,70). Recently, using
electron microscopy, long flaps (median of ∼100–150 nt,
but some longer than 1000 nt) were directly shown to accu-
mulate behind replication forks in vivo in S. pombe dna2 or
rad2 (Fen1) mutants (71). Electron microscopy also directly
demonstrated that long flaps accumulated in S. cerevisiae
dna2 mutants and that such accumulation was reduced by
90% when Pif1 was ablated using a pif1-m2 mutation in
a dna2Δ strain (65). Finally, conventional in vivo pulse-
labeling experiments and gel electrophoresis of nascent
DNA in yeast showed that Okazaki-sized fragments accu-
mulate at telomeres, but not at ribosomal DNA (rDNA), in
the absence of either scDNA2 or scFEN1 (72). Taken to-
gether, these results strongly support that the function of
scDNA2 in the removal of long RNA–DNA flaps is essen-
tial for DNA replication and cell viability in yeast.
However, deep sequencing of Okazaki fragments in yeast
was recently used to test the relative contributions of the
various Okazaki fragment processing pathways in vivo. Sur-
prisingly, scDNA2 depletion did not significantly affect
the maturation of the sequences queried by this technique
(45). This result remains puzzling, considering the abun-
dance of evidence suggesting, as summarized above, that
the long-flap pathway is also important in vivo. The ex-
planation perhaps lies in the details of the Okazaki frag-
ment sequencing technique or in the fact that engage-
ment of the long-flap pathway, though essential, is statis-
tically very rare. In addition, experiments in human cells
revealed that yet another pathway, mediated by human
poly (ADP-ribose) polymerase (PARP) and the SSB re-
pair protein XRCC1, might also be involved in the matura-
tion of unligated Okazaki fragments that appear as SSBs,
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Figure 3. Roles of DNA2 in resolving DNA secondary structures, as typified by G4s, to facilitate DNA replication and repair. DNA2 endonuclease activity
can directly excise G4s obstructing DNA replication fork movement. The resulting ssDNA gap is repaired by high-fidelity SSB repair. DNA2 can also
remove G4s fromDSBs to enable efficient end resection. The resolution of G4s by DNA2 is particularly crucial in the presence of G4 stabilizers that inhibit
G4 unwinding by other helicases.
gaps, or flaps, and might be induced in the absence of
DNA2 (73).
Indeed, in human cell lines, replication forks do not pro-
ceed more slowly after knockdown of DNA2, as shown
by fiber tracking (74). Furthermore, homozygous Dna2
knockout mice are viable until embryonic day 8.5 (E8.5),
and Dna2 knockout in mouse embryonic stem cells only
slows DNA replication and is not lethal (21,75). These
results suggest that DNA2-mediated RNA-DNA primer
removal is not an essential pathway for Okazaki frag-
ment maturation in mammalian cells, perhaps due to the
PARP pathway and greater flexibility among the various
Okazaki fragment-processing enzymes. Nevertheless, hu-
man HCT116 cells also lose viability precipitously after
DNA2 ‘shut-off’ [(76) and unpublished], suggesting an es-
sential function of DNA2 other than Okazaki fragment
maturation during DNA replication and cell proliferation.
Facilitating the replication of ‘difficult-to-replicate’ DNA re-
gions
Across the genome, there are many fragile, or ‘difficult-to-
replicate,’ sites that pose challenges for the replisome and
act as an endogenous source of replication stress. Cells have
developed several mechanisms to facilitate the replication
of these sequences. DNA2 in particular has been shown to
be a key enzyme in facilitating the replication of the ma-
jor difficult-to-replicate regions, rDNA, telomeres and cen-
tromeres, which contain various types of putative replica-
tion fork-blocking structures (Figure 3) (21,55,77,78).
rDNA loci, which encode the ribosomal RNA genes, are
organized in clusters of tandem repeats. It is estimated that
there are 100–150 repeated ∼9–10-kb rDNA units in the
rDNA loci of S. cerevisiae (79). Also within rDNA loci
are cis-elements (∼100 bp), namely replication fork barriers
(RFBs), that are tightly bound by the RFB-binding protein
scFob1 (80). These RFB-Fob1 complexes must be resolved
or bypassed during DNA replication. Yeast genetic studies
revealed that helicases, including scDNA2, RecQ-like SGS1,
andRRM3, are required to enable replication forks tomove
through RFBs in rDNA regions (78,81–83). Genetic defi-
ciencies in scDNA2, SGS1 or RRM3 cause replication fork
pausing, and deficiencies in scDNA2 and SGS1 additionally
lead to DSB formation in the rDNA region. In contrast,
Pif1 helicase helps maintain RFBs, which were less com-
mon in pif1 mutants (83). The rDNA pause phenotype in
dna2, sgs1 and rrm3 mutant strains was suppressed upon
deletion of the FOB1 gene, suggesting an important role of
these helicases in resolving the RFB–Fob1 complex to fa-
cilitate DNA replication at rDNA loci. These helicases may
directly promote replication fork progression through the
protein-DNA complex and/or participate in the resolution
of converged DNA replication forks formed at the RFBs.
In keeping with this idea, scDNA2 was also found to in-
teract with genes encoding Pol  and CTF4/AND-1, the
latter of which is now known as a hub for the interaction of
the CMG (Cdc45-MCM-GINS) helicase complex with Pol
 and other proteins, including DNA2 (9,84). The DNA2
and CTF4/AND1 interaction has been proposed to be sig-
nificant for rDNA maintenance in both yeast and human
(78,82,84).
Telomeres are specialized DNA-protein structures that
protect chromosome ends from inappropriate degradation
and fusion (85,86). They are greatly important for main-
taining genome integrity and avoiding neoplastic transfor-
mation. Telomeres not only cap chromosome ends but also
have a reversible ‘telomeric silencing’ effect on genes in-
ternal to the terminal repeats. However, overexpression of
scDNA2 disrupted the silencing of genes inserted into yeast
subtelomeric DNA (87). Study of this phenomenon showed
that scDNA2 localizes to telomeres in a Sir3-dependent
and cell cycle phase-specific program (55). It localizes to
telomeres during the G2 phase and is also present at telom-
eres in G1. In S phase, however, it relocates to origins of
replication. scDNA2 also delocalizes from telomeres when
DSBs are introduced upon bleomycin treatment. DNA2
was also shown to localize to telomeres in mammalian cells
via interactions with telomere-binding factors TRF1 and
TRF2 (21). Based on the interaction of scDNA2 with Sir3
at telomeres, as well as its role in rRNA stability, its con-
tribution to aging was investigated in yeast. dna2 mutants
had shortened replicative life spans, indicative of premature
aging (88). In humans, a splice-site mutation that leads to
decreased levels of DNA2 was found to enhance cellular
senescence and gives rise to Seckel syndrome, a type of pri-
mordial dwarfism (PD) (89), thus illustrating the conserved
impact of DNA2 on aging and development.
At least one function of DNA2 at telomeres may in-
volve secondary G-quadruplex (G4) structures, which form
in regions of guanine (G)-rich ssDNA (85). Indeed, telom-
eres consist of long tracts of G-rich tandem repeats
[(TTAGGG)n in humans], and G4 structures have been
detected at telomeres using structure-specific antibodies
and proteins that recognize G4s in cells (90–93). G4s are
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gkz1101/5637586 by C
alifornia Institute of Technology user on 25 N
ovem
ber 2019
Nucleic Acids Research, 2019 7
defined by stacks of two or more G-quartets, which are
formed by four Gs associated via Hoogsteen base-pairing,
stabilized by a monovalent cation (94). G4s are particu-
larly problematic for DNA replication machinery, because
they form spontaneously and are thermodynamically sta-
ble (95,96). Unresolved G4s can block replication fork
progression, and ligands that stabilize G4s inhibit telom-
ere DNA replication, suggesting that G4 DNA is patho-
logical (95). Many pathways have been found to resolve
and/or clean upG4 barriers to allow efficient DNA replica-
tion. The most well-known mechanism is G4 unwinding by
DNA helicases, including FANCJ, PIF1, RTEL1, RECQ5,
BLM,WRNandG4R1 (97–104). These helicases have been
shown to promote DNA replication at telomeres and other
G4-forming sequences. In addition, the DNA replication
protein complexes RPA (RPA1, RPA2 and RPA3) and CST
(CTC1, STN1, and TEN1) can directly unfold G4 struc-
tures (105,106). However, the unfolding or unwinding of
G4s typically requires an ssDNA tail on which to load the
RPA, CST or G4 helicases (102,105,106). Moreover, G4-
stabilizing chemicals and G4-binding proteins significantly
inhibit the ability of helicases to resolve G4s (102). To en-
sure protection against a potential lack of an ssDNA tail
and/or G4 stabilization, another mechanism is needed to
resolveG4s. Both scDNA2 andmammalianDNA2 can rec-
ognize and effectively unwind and cleaveG4 structures, pre-
sumably removing the G4s ahead of the replication fork
to facilitate fork progression (Figure 3) (21,107). In fact,
scDNA2 deficiency results not only in telomere shortening
but failure to join telomericOkazaki fragments (55,72), sug-
gesting roles in the resection and replication of telomeres.
DNA2 deficiency in mammalian cells also leads to telom-
ere fragility and shortening, as well as hyper-recombination
between sister chromatids (21). These results suggest a con-
served role of DNA2-mediated G4 resolution in facilitat-
ing telomere DNA replication and perhaps replication of
G-rich chromosomal sequences.
Centromeres, which orchestrate chromosome segrega-
tion, contain the largest clusters of tandem repeats in the
human genome, namely  satellite DNA (108). The basic
units of  satellite DNA consist of 171-bp sequences, which
formhighly homologous arrays of up to severalmillion base
pairs at the centromeres of all human chromosomes. These
 satellite repeat sequences also place a burden on DNA
replicationmachinery, due to their tendency to formvarious
secondary structures on both the DNA template and the ss-
DNA flaps of the newly synthesized daughter strand DNA
(109). Factors that facilitate centromere DNA replication
were unknown until recently. A study using proteomic and
biochemical approaches demonstrated that the DNA re-
pair proteins MSH2 and MSH6 are crucial for efficient
centromere DNA replication (110). Importantly, this study
also demonstrated that inhibition of RPA and the down-
stream kinase ATR is critical for centromere DNA repli-
cation (110). Chromatin immunoprecipitation sequencing
technology revealed that, under normal physiological con-
ditions, nuclear human DNA2 localizes predominantly to
centromeres (77), and singlemolecule analysis of replication
dynamics (SMARD) and other techniques revealed that
DNA2 has several functions during centromere DNA repli-
cation (77). First, its helicase activity can help to resolve
stem–loop structures on the DNA template strand (Table
1). Second, its helicase and nuclease activities can work to-
gether to effectively remove RNA-DNA flaps that contain
secondary structures (Table 1). Third, it may help to process
the centromere DNA to ensure the proper formation of sec-
ondary structures that have recently been found to be criti-
cal for loading the centromere-binding protein CENPA and
for suppressing RPA binding and ATR activation at cen-
tromeres. Supporting this postulated function, DNA2 de-
ficiency was found to impair CENPA loading but enhance
RPA binding and ATR activation at centromeres (77).
End resection for checkpoint activation, homology-directed
repair and telomere end protection
DNA molecules in eukaryotic cells constantly experience
DNA damage. DSBs, due to endogenous or environmental
genotoxic insults, constitute the most lethal and mutagenic
type of DNA damage (111–113), and cells must repair them
immediately and with high fidelity. Unrepaired DSBs can
cause apoptosis or cellular senescence, whereas improper
repair can cause chromosomal translocations and deletions
(111–113). As a result, highly sophisticated and conserved
systems have evolved in eukaryotic cells to rapidly detect
and efficiently repair DSBs. To date, three major pathways
forDSB repair have been defined: homology-directed repair
(HDR), classical non-homologous end-joining (c-NHEJ),
and alternative non-homologous end-joining (Alt-NHEJ)
(114). HDR requires extensive DSB end resection to gener-
ate 3′ ssDNA overhangs that subsequently invade homol-
ogous DNA duplexes to create D-loop structures. These
homologous recombination intermediates are unwound, re-
sulting in high fidelity repair of DSBs. The 3′ ssDNA over-
hangs also serve as signals to induce activation of ATR sig-
naling. In contrast, c-NHEJ, which is also highly accurate,
requires no DNA end resection. Instead, c-NHEJ machin-
ery directly joins brokenDNAends. The third pathway, Alt-
NHEJ, involves limited DNA end resection to generate re-
gions of micro-homology to facilitate annealing and end-
joining. This error-prone pathway frequently causes chro-
mosomal translocations.
HDR is initiated by DNA end resection of DSBs (113).
The 3′ overhang of the resected ends recruits RPA and ac-
tivates the DNA replication or DNA damage checkpoint
through CHK1 or CHK2, depending on the nature of the
damage (115). RPA is then replaced by Rad51, and the
Rad51 filament initiates HDR. The observation that yeast
dna2 mutants were sensitive to X-rays provided the first in-
dication that DNA2 may participate in DSB repair (116).
In addition, its nuclease/helicase activities were strikingly
similar to those of RecBCD, which is the primary end pro-
cessing enzyme in E. coli (10). A role in DSB repair was
also suggested by a global synthetic lethal screen, which un-
expectedly revealed that dna2 mutations were synthetically
lethal with mutations to the DNA repair protein Sgs1 but
not with mutations to DNA repair proteins Rad51, Rad55,
Rad57 and Rad59 (69). In addition, BLM, the human or-
tholog of Sgs1, was also shown to suppress the DNA re-
pair defects of yeast dna2 mutants and to interact with
scDNA2 (117). This is consistent with subsequent genetic
and biochemical studies, which indeed defined DNA2 as a
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critical nuclease that acts in conjunction with RecQ heli-
cases (Sgs1/BLM) to resect 5′ ends of DSBs for checkpoint
activation and HDR in yeast (118–122). The function of
DNA2 in DSB end resection is also conserved in higher eu-
karyotic organisms, including Xenopus (123,124), chicken
(125), and human, as shown by the accumulation of RPA
and Rad51 foci upon DNA2 depletion and through other
biochemical methods (126,127). In S. cerevisiae, the MRX
(Mre11-Rad50-Xrs2) complex or Sae2 nuclease (CtIP in
humans) initiates 5′ degradation of broken ends, and an
Sgs1/scDNA2 complex continues to cleave the DNA in the
5′-to-3′ direction to generate an extensive 3′ ssDNA over-
hang (118,121,122).
Using point mutations that specifically eliminate the
helicase activity of Sgs1 or scDNA2, it was found that
the Sgs1 helicase, but not the scDNA2 helicase, unwinds
the DNA duplex to create ssDNA flaps (121). In single-
molecule studies, it has been shown that Sgs1 is recruited
to DNA ends through either Top3-Rmi1-dependent or -
independent pathways (128). These studies also showed that
the Sgs1 end processing machinery can rapidly displace in
vitro reconstituted nucleosomes, but is not activated until
scDNA2, including nuclease- and ATPase-dead scDNA2,
is added. Once the ssDNA overhangs have been generated,
the scDNA2 nuclease is activated for resection, but only
in the presence of RPA. RPA binds and sequesters the ss-
DNA unwound by Sgs1. Single-molecule analysis of hu-
man DNA resection proteins identified phospho-RPA as
an inhibitor of the BLM helicase during DNA2- or EXO1-
mediated resection (129). Importantly, the binding of RPA
to ssDNA stimulates the 5′ nuclease activity and inhibits
the 3′ nuclease activity of scDNA2, thereby leading to se-
lective 5′ end resection by scDNA2 (107,118,121). The crys-
tal structure of a peptide containing the 1 helix of hu-
man DNA2 (residues 1–20) in complex with the OBN do-
main of human RPA70 (residues 1–120) explains how RPA
regulates the polarity of DNA2 nuclease activity (35). In
yeast cells, Exo1, redundantly with the Sgs1/scDNA2 com-
plex, mediates long-range end resection (122). ScDNA2-
andExo1-mediated end resection is both positively and neg-
atively regulated by the 9-1-1 checkpoint clamp and nega-
tively regulated by the checkpoint mediator Rad9 (53BP1
in humans) (130). However, the yeast chromatin remodeler
Fun30 (SMARCAD1 in humans), which is required for re-
section in vivo, is thought to overcome inhibition by Rad9
(131–133). InXenopus, the ortholog of helicaseWRN (Ffa-
1), another RecQ helicase, associates with Dna2 for resec-
tion (134).
Telomeres represent specialized DSBs. Immediately fol-
lowing telomere replication, the C-rich strands at the telom-
ere ends are resected in a series of steps to generate G-
overhangs, which form t-loop structures that protect the
chromosome ends from being recognized as toxic, recom-
binogenic DSBs (135–137). Genetic studies in yeast suggest
that scDNA2 plays a critical role in telomere end resection
to generate 3′ G-overhangs on the newly synthesized lag-
ging strand (72,138,139). Another recent study, however,
reported that the Apollo and EXO1 nucleases resect the
nascent leading strand of mammalian telomere ends (135).
These findings indicate that eukaryotic cells from differ-
ent organisms use distinct resection mechanisms to process
telomere ends for t-loop formation.
Processing of stalled replication forks
Efficient and accurate DNA replication is essential to en-
sure that daughter cells faithfully receive genetic material
and ultimately survive (140). However, DNA replication
machinery is frequently challenged by DNA lesions, sta-
ble secondary DNA structures and DNA-bound protein
complexes. In each of these situations, the replication fork
stalls, and if repair is not efficient, the forks collapse into
DSBs or other structures, notably gaps. The proper mainte-
nance, processing, and restarting of the stalled or collapsed
or uncoupled replication forks are of paramount signifi-
cance for cells, as mishandling of the damaged forks can
lead to genome instability, tumorigenesis, or cellular lethal-
ity (140). Thus, several mechanisms have evolved in eukary-
otic cells to manage stresses on the replication fork. When
replication forks transiently stall in response to replication
stresses, electron microscopy reveals two major intermedi-
ates: single-stranded gaps either at or behind the fork and
reversed fork structures (141). ssDNA is generated, in some
cases due to the uncoupling of DNA polymerase from the
replicative helicases, and/or by the processing of reversed
forks (4,142). The accumulation of ssDNA can lead to the
binding of RPA, which subsequently recruits and activates
MEC1 in yeast cells or ATR in mammalian cells. Acti-
vated MEC1/ATR coordinates different pathways to stabi-
lize, process, or restart the stalled replication forks, depend-
ing on the nature of the impediment, the structure of the
forks, and the availability of DNA replication and repair
proteins.
DNA2 has been defined as a central factor in counter-
acting stresses on replication forks. Its helicase and nucle-
ase activities can resolve stable secondary structures, in-
cluding stem–loops and G4s (Figure 3), thus removing in-
trinsic replication barriers and preventing replication fork
stalling (21,77,107). Furthermore, when restarting stalled
replication forks, it is crucial to maintain the proper con-
figuration of the fork to avoid the formation of intermedi-
ate structures that will potentially generate deleterious gaps
or DSBs. One such intermediate is the regressed fork struc-
ture, in which the template rewinds and the nascent lead-
ing and lagging DNA strands anneal to each other to form
a four-way DNA structure resembling a Holliday junction
(HJ). Although this is an important structure for restart-
ing the fork, if repair is not efficient, it may be cleaved by
HJ resolvases or endonucleases, such as Mus81, to create
one-ended DSBs. These DSBs can be used for recombina-
tion restart but can also be toxic. DNA2 plays several roles
in resolving regressed forks and in several other stages of
stalled fork processing and restarting. For example, in S.
pombe, in response to fork stalling induced by hydroxyurea,
ATR is activated by phosphorylation. The active form of
ATR can then phosphorylate Cds1 (a CHK2 homolog),
which subsequently phosphorylates Dna2 at residue S220,
which promotes the association between Dna2 and chro-
matin (143). Biochemical studies using model substrates
that mimic four-way replication forks with nascent, unan-
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nealed 3′ and 5′ leading and lagging DNA strands showed
that Dna2 is capable of degrading 5′ or 3′ ssDNA before the
fourth arm can form (Figure 4) (143). In this way, DNA2
may help prevent deleterious consequences of fork reversal.
DNA2 can also directly act on regressed fork structures
to facilitate their proper resolution and fork restart (Figure
4). TheVindigni group showed that limitedDNA2 resection
is required to restart forks arrested by hydroxyurea in hu-
man osteosarcoma U2OS cells (22). The DNA2-mediated
degradation of nascent DNA at stalled forks is stimulated
by WRN and RAD51 (144,145) but inhibited by RECQ1
(22). Specifically, DNA2 and WRN were shown to resect
four-way DNA structures with a 5′-to-3′ ssDNA overhang
on one arm in vitro (22), andRAD51 andRECQ1were pro-
posed, respectively, to increase and counteract fork rever-
sal. Evidence for DNA2 degradation of DNA after fork re-
versal was provided by electron microscopy, which showed
that DNA2 depletion resulted in significant accumulation
of revered forks, even in unperturbed U2OS cells. Further-
more, more reversed forks were double-stranded in DNA2-
depleted cells than in normal cells, suggesting that nascent
DNA is degraded by DNA2 on the reversed fork structures,
generating the ssDNA overhangs. Once forks are reversed,
a motor protein, such as RecQ helicase or theDNA translo-
case SMARCAL1, can act via a branch migration mecha-
nism to restart the partially resected, reversed forks with 3′
overhangs (22,146). In yeast, scDNA2 has also been impli-
cated in reversed fork resolution because it stimulates EXO1
to resect the nascent, annealed regressed fork DNA to elim-
inate aberrant replication intermediates in cells that are
replication checkpoint-defective (147). In addition, knock-
down of Merit40, which is a fork protection protein in-
volved in recruitment of BRCA1, also appears to synergize
with DNA2 knockdown, suggesting that they participate
in parallel processes of fork protection/restart (148). This
pathway might occur at gaps, which may arise after nucle-
ase degradation of DNA flanking interstand crosslink or
DNA gaps being repaired by post-replication repair pro-
cesses (6,149). It offers an alternative to reversed forks for
replication restart (Figure 4). MRE11 or EXO1 is sug-
gested to process the gap to initiate Rad51-mediated sister-
chromatin exchange (SCE) (149). However, it is not known
if DNA2 plays any role on these gaps.
DNA2 and other nucleases are critical for properly
restarting stalled replication forks and for maintaining
genome integrity; however, the uncontrolled activities of
DNA2, EXO1 and MRE11 can also result in unscheduled
or over-resection of stalled replication forks, contributing
to genome instability (Figure 4) (141,150,151). Many fac-
tors have been found to regulate DNA2-mediated resec-
tion activity at stalled replication forks. Binding of the hi-
stone H3K4 methylase SETD1A or BOD1L, a SETD1A
subunit, to the stalled replication fork stabilizes RAD51
and inhibits DNA2- and BLM-dependent fork resection
(75,152,153). Interestingly, while RAD51 promotes the ac-
tion of DNA2 on regressed forks during fork restart, prob-
ably by aiding in fork reversal, it also plays a critical role
in protecting the fork from excessive degradation by DNA2
(56,69) and other nucleases (150,152), possibly by binding
to the 3′ ssDNA overhang. DNA2-dependent fork resec-
tion is also controlled by ABRO1 (154), which is a para-
log of the BRCA1-binding protein Abraxas (155). A more
recent study suggested that CtIP is also critical in prevent-
ing DNA2-mediated over-resection of the stalled replica-
tion fork. It was postulated that CtIP, which inhibits EXO1
nuclease activity in vitro (156), controls the nuclease activ-
ities of DNA2 and EXO1 to limit resection. In addition,
human RIF1 inhibits the phosphorylation of WRN and of
DNA2 to limit the formation of DNA2-WRN complexes
and inhibit fork degradation by DNA2 (157,158) . Finally,
telomerase was also found to stabilize reversed replication
forks that formed in telomeric DNA due to unresolved t-
loops and G4s in RTEL1-deficient cells, potentially by pre-
venting normal fork restart mediated by telomeric DNA2
(159).
New studies on epigenetic modifications and histone mo-
bility suggest that events at stalled forks explain the old
observation in yeast that dna2-1, dna2-2 and dna2Δ pif1Δ
mutations are synthetically lethal with mutations in chro-
matin remodeling and histone chaperone genes. Early on, it
was found that dna2-2 caused synthetic sickness with mu-
tations to spt16 and pob3, which are components of the
FACT chromatin remodeling complex that interact with Pol
 (69,160). It was proposed that these interactions might
facilitate the progression of Pol  and DNA2 through nu-
cleosomes. More relevant to replication fork stalling, it was
demonstrated that dna2mutations were synthetically lethal
with mutations to the Rad6/Bre1 complex, which is in-
volved in histone H2B ubiquitination and is required for
histone H3 lysine methylation, as well as with mutations
to several genes in the COMPASS/Set1 histone methylase
complex. This suggested a link between epigenetic modifi-
cations, DNA2 function, and genome stability, because the
COMPASS mutants were hydroxyurea-sensitive.
Themechanisms underlying these synthetic lethality phe-
notypes are just beginning to emerge in human cells. Stewart
group discovered that loss of human BOD1L, the SETD1A
histone H3K4 methylase subunit, led to sensitivity to inter-
strand cross-links due to loss of replication fork protec-
tion and over-resection of nascent DNA (153). They fur-
ther suggested that H3K4 methylation by SETD1A pro-
motes RAD51 filament formation, which limits DNA end
resection by DNA2. They also showed that, in the absence
of methylation, depletion of DNA2 suppressed inter-strand
cross-link sensitivity and reduced resection of nascent
DNA. Interestingly, the histone chaperone/nucleosome as-
sembly function of FANCD2, a known fork-protection
and inter-strand cross-link repair protein, is stimulated by
H3K4, and suppression of either H3K4 methylation or
the histone chaperone activity of FANCD2 led to over-
resection that correlated with loss of RAD51 filament for-
mation (Figure 4) (152,153). More recently, the Moldovan
group showed that incomplete Okazaki fragment matura-
tion and gap-filling due to defective PCNA ubiquination
interferes with CAF1-driven histone deposition. They pro-
pose that the altered histone deposition process impairs pro-
tection of stalled replication forks, leading to DNA2-driven
fork degradation (151). Clearly, the diverse, multi-layered
reactions at stalled forks need to be reconstituted and stud-
ied biochemically, as was done to understand the sequential
reactions during Okazaki fragment maturation, to test the
many possible mechanisms and determine the specific con-
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Figure 4. Multiple functions of DNA2 in stalled replication fork processing. DNA2 can participate in stalled replication fork protection, limited resection,
or over-resection, depending on the nature of the fork and the availability of other fork-protecting factors. To protect a replication fork, the 5′ nuclease
activity of DNA2 may cleave the 5′ ssDNA flap, preventing the reversal of nascent DNA, which can lead to the formation of potentially deleterious
regressed fork structures. If regressed forks do arise, however, the 5′ nuclease activity of DNA2 may conduct limited 5′ resection, generating a 3′ ssDNA
overhang to facilitate the helicase-driven regression of the regressed fork structure to restart the fork. Meanwhile, BRCA2may be recruited to the regressed
fork structure to limit the action of DNA2 to avoid over-resection. In addition, SET1A, in complex with BOD1L, catalyzes H3K4 methylation, which
facilitates FANCD2-mediated histone assembly on the regressed fork and stabilizes the RAD51 filament on the nascent DNA to protect the fork before
restarting. In the absence of BRCA2 or BOD1L, extensive degradation of the regressed fork by DNA2 and other nucleases may occur, leading to fork
collapse and genome instability. In addition, the lesion that blocks leading strand DNA synthesis may be bypassed by the repriming process. The resulting
gap will be processed and repaired post replication. The role of DNA2 in processing of the gap is undefined.
tributions of each of these mechanisms and how they are
used at different types of stalled forks.
Mitochondrial DNA replication and repair
An unexpected function for DNA2 in mitochondria was
discovered through studies instigating how inhibition of
the nuclear functions of PIF1 suppresses the lethality of
dna2Δ in yeast. The mutant pif1-m2, which has an intact
mitochondrial localization signal but an inactivated NLS,
demonstrates proficient mitochondrial replication and can
grow on non-fermentable carbon sources but is deficient in
nuclear Pif1 functions (which are not essential for viabil-
ity). pif1-m2, like pif1Δ, was found to suppress the lethal-
ity of dna2Δ. However, the pif1-m2 dna2Δ double mutant
lost mitochondrial DNA (mtDNA) rapidly and could not
grow on non-fermentable carbon sources, establishing that
DNA2 was necessary for mtDNA stabilization (56).
The same was shown for metazoans. Mammalian
mtDNA is a circular molecule of approximately 16 kb. Each
cell contains hundreds to thousands of mitochondria, and
each mitochondrion contains several copies of the mtDNA
genome (161). mtDNA is typically replicated via a strand
displacement mechanism (161), which requires unwinding
of the DNA template by a helicase. Human DNA2 has
been demonstrated to localize to mitochondria and to be
required for the stability of mtDNA, as well as base ex-
cision repair (BER) (Figure 5) (14,162). Interestingly, hu-
man DNA2 has a predicted N-terminal mitochondrial lo-
calization signal peptide, but the peptide does not play a
role in mediating DNA2 mitochondrial localization (14).
Instead, a region within the helicase domain of DNA2 is es-
sential for its mitochondrial localization. When this region
is fused to GFP, the GFP localizes to mitochondria, sug-
gesting that it is a new mitochondrial targeting motif (14).
Mitochondrial DNA2 interacts with mitochondrial Pol 
and greatly enhances the activity and processivity of Pol  -
mediated strand displacement DNA synthesis in vitro (14).
However, replication forks similar to those generated dur-
ing nuclear DNA replication have also been observed in
mtDNA using 2D gel electrophoresis, suggesting that repli-
cating mtDNA also uses a strand-coupled DNA replica-
tionmechanism (163,164), whichmay involve the sequential
actions of DNA2 and FEN1 to remove RNA–DNA flaps
(14,162,165).
REGULATORY MECHANISMS
Protein-protein interactions
DNA2 forms complexes with various proteins, including
DNA replication proteins, DNA repair proteins, telomere-
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Figure 5. Mitochondrial localization and TRAF6-mediated nuclear
translocation of human DNA2. Like its yeast counterpart, human DNA2
migrates into both mitochondria and nuclei. However, unlike scDNA2,
human DNA2 has no NLS and translocates into nuclei via an NLS-
independent mechanism that depends on TRAF6-mediated polyubiquiti-
nation. Once in the nucleus, DNA2 can localize to telomeres, centromeres
or the nucleolus to facilitate the DNA replication of these difficult-to-
replicate regions. DNA2 can also be recruited stalled replication forks or
DSBs to facilitate the repair of these intermediate structures via the HDR
pathway.
binding proteins, and protein-modifying enzymes (Table 2).
In general, these protein-protein interactions facilitate the
functions of DNA2 in different DNA metabolic pathways
by recruiting it to DNA replication or repair sites or by
stimulating its nuclease or helicase activities. scDNA2 in-
teracts with RPA and FEN1 to efficiently process long flaps
during Okazaki fragment maturation (11,12,14,46). RPA
recruits scDNA2 to long RNA-DNA flaps, stimulates its
nuclease activity to cleave the long flaps, and coordinates
its sequential actions with FEN1 (11). Additional studies
revealed that RPA may stimulate the nuclease activity of
scDNA2 by melting the secondary structures on the 5′ flaps
during Okazaki fragment maturation (54). Compared to
scDNA2, human DNA2 lacks approximately 400 amino
acid residues in its N-terminus, including the RPA interac-
tion motif (12,19,20). Thus, the effects of RPA on DNA2
likely differ between species. Indeed, Seo group suggests
that RPA does not stimulate the human DNA2-catalyzed
cleavage of 5′ ssDNA from the a duplex DNA substrates
at low concentrations and inhibits such cleavage at high
concentrations (19). However, studies from other groups
suggest that the interactions between RPA, mammalian
DNA2, and the DNA substrate ensure that DNA2 specif-
ically cleaves the 5′ ssDNA strand and not the 3′ ssDNA
strand during DSB end resection (127). In addition, RPA
melts secondary structures on the 5′ ssDNA, further pro-
moting the cleavage of 5′ flap by mammalian DNA2 (35).
In fission yeast, it was shown that Dna2 interacts with the
replication protein Cdc24 and that the Dna2/Cdc24 inter-
action may stimulate Dna2 to cleave the RNA–DNA flap
(58). Intriguingly, no Cdc24 homologs have been identified
in other species (58).
In response to DNA replication stress, DNA2 interacts
with PCNA and participates in processing and restarting
stalled or collapsed replication forks (63). During DSB re-
pair, DNA2 interacts with BRCA1, CtIP and RecQ heli-
cases (Sgs1 in yeast orWRNandBLM inmammalian cells).
BRCA1 and CtIP are crucial for recruiting DNA2 to DSB
sites in human and chicken DT40 cells (125). The interac-
tion between DNA2 and the RecQ helicases stimulates the
nuclease activity of DNA2 (122,127,144). A recent study re-
vealed that the DNA repair protein complex 9-1-1 also in-
teracts with and facilitates the function of DNA2 in resect-
ing DSB ends (130). In addition, DNA2 interacts with the
inter-strand cross-link repair protein FANCD2 in U2OS
cells, and knockdown of DNA2 suppressed the sensitivity
of FANCD2-deficient cells to the DNA cross-linking agent
cisplatin, suggesting a role for a putative DNA2/FANCD2
complex in the Fanconi anemia/BRCA pathway (126).
The interaction between DNA2 and the telomere-
binding proteins TRF1 and TRF2 is important for the lo-
calization of DNA2 to telomeres and for DNA2-mediated
end resection of telomere ends (21). In addition, mito-
chondrial DNA2 interacts with mitochondrial Pol  for
mtDNA replication and repair (14). Another category of
DNA2 interaction partners are proteins that mediate the
post-translational modification and co-factor assembly of
DNA2, including p300 (166), Cdk1 (167), Cds1 (a CHK2
homolog) (143) and MMS19 (168), which catalyze the
acetylation, phosphorylation, and Fe–S cluster assembly of
DNA2, respectively.
Post-translational modifications of DNA2
To date, three major post-translational modifications of
DNA2 have been identified. Acetyltransferase p300 is re-
ported to interact with and acetylate human DNA2 in vitro
and in cells (166), and acetylation of DNA2 by p300 is stim-
ulated by UV irradiation. Acetylated DNA2 has 10-fold
higher DNA binding affinity, as well as greater nuclease,
helicase, and ATPase activities, than non-modified DNA2
(166). Acetylation has been proposed to serve as a switch
that directs RNA-DNA flap cleavage, because it inhibits
FEN1 while stimulating DNA2, thus promoting the long-
flap pathway (166). This switchmight be useful in increasing
the size of the patch of re-synthesis during Okazaki frag-
ment processing or DNA repair, providing a greater op-
portunity for the correction of error-prone synthesis by Pol
 or of damaged bases, respectively (166). Phosphoryla-
tion has been reported to play a crucial role in facilitating
the function of DNA2 in stalled replication fork process-
ing and in DSB end resection. In response to replication
stress in fission yeast, Dna2 is phosphorylated by Cds1 at
the S220 residue (143). S220 phosphorylation of Dna2 pro-
motes its recruitment to stalled replication forks, as well as
the cleavage of nascent strands to prevent the formation of
potentially deleterious regressed fork structures (143). In-
deed, mutation of S220 causes the dissociation of DNA2
from chromatin after DNA damage. Meanwhile, scDNA2
is phosphorylated at Thr4, Ser17, and Ser237 residues by
Cdk1 in response toDSBs. Cdk1-dependent scDNA2 phos-
phorylation stimulates its localization to the nucleus and
to DSB sites (167). scDNA2 is also phosphorylated by the
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gkz1101/5637586 by C
alifornia Institute of Technology user on 25 N
ovem
ber 2019
12 Nucleic Acids Research, 2019
Table 2. DNA2 interaction proteins and the pathways in which the complexes are formed
Protein Pathways Organism References
RPA Okazaki fragment maturation Sc. H. (11,12)
RPA DSB end resection Sc. H (118,127)
PCNA Replication fork processing H. (23)
FEN1/Rad27 Okazaki fragment maturation Sc. H (14,46)
CTF4 Okazaki fragment maturation Sc. (9)
CTF4 DSB end resection Sc. (78,82,84,124)
Cdc24 Okazaki fragment maturation Sp. (58)
BRCA1 DSB end resection C. (125)
CtIP DSB end resection C. (125)
Sgs1/WRN, BLM DSB end resection Sc. H. (12,122,125,144)
9-1-1 DSB end resection Sc.H. (130)
FANCD2 Replication fork processing H. (126)
TRF1 Telomere replication M. H. (21)
TRF2 Telomere replication M. H. (21)
Pol  mtDNA replication, repair H. (14)
Cdk1 DSB end resection Sc. (167)
Cds1 Replication fork processing Sp. (174)
p300 UV damage repair H. (166)
TRAF6 Nuclear location H. (170)
MMS19 Iron-sulfur cluster assembly Sc. H. (168)
Sc.: S. cereviasiae, H.: human; M.: mouse; Sp.: S. pombe; C.: chicken.
checkpoint kinaseMec1, although the role of this phospho-
rylation has not been established (167). Proteomic analyses
of endogenously ubiquitinated proteins in human cells re-
vealed that DNA2 is ubiquitinated at multiple sites across
the protein (169).
It has recently been reported that, in humans, nu-
clear DNA2 is ubiquitinated. In response to DNA dam-
aging agents, such as camptothecin and hydroxyurea,
DNA2 ubiquitination levels increased significantly (170).
Furthermore, it was found that the human E3 ligase
TRAF6 binds to DNA2 and mediates its K63 ubiq-
uitination. TRAF6-mediated DNA2 ubiquitination pro-
motes its stability and nuclear localization (Figure 5) (170).
This TRAF6-mediated spatial regulation mechanism helps
to answer the fundamental question of how mammalian
DNA2, which lacks an NLS, migrates into nuclei and binds
to chromatin during S phase or in response to endoge-
nous or environmental genotoxic stresses. Polyubiquitina-
tion of DNA2 may enhance its interaction with ubiquitin-
binding domain (UBD)-containing proteins that have an
NLS and allow DNA2 to migrate into nuclei via a piggy-
back transport mechanism (171). Alternatively, the K63-
linked ubiquitin chain, which has direct DNA-binding ac-
tivity (172), may promote DNA2 nuclear localization via
an NLS-independent nuclear localization mechanism, sim-
ilar to that used by the nuclear protein MeCP2 (173). This
mechanism of regulation of nuclear localization is quite dif-
ferent from that proposed in yeast, which involves phos-
phorylation of the N-terminal regulatory region by Cdc28
(homologous to human CDK1 and CDK2) (174). Genetic
or chemical inhibition of TRAF6, as well as DNA2 non-
ubiquitination mutations, abolished both the ubiquitina-
tion and nuclear localization of DNA2 and consequently
impaired DNA end resection and HDR of DSBs.
In yeast, scDNA2 is regulated by the SUMOylation of
its N-terminal regulatory domain, a region not found in
the human enzyme (175). SUMOylation inhibits the nucle-
ase but not the helicase activity of DNA2 in vitro and tar-
gets DNA2 for degradation in vivo. In non-SUMOylatable
dna2 mutants, total Dna2 levels were higher than in strains
with SUMOylatable Dna2, but recruitment to nuclei was
lower. End resection was also somewhat defective and S
phase lengthened in the non-SUMOylatable mutants (175).
Thus, DNA2 regulation seems to differ in humans and
yeast.
Fe–S cluster assembly can be considered a post-
translational modification. The Campbell group has shown
that the scDNA2 protein contains an Fe–S cluster domain,
consisting of four conserved cysteine residues, C519, C768,
C771 and C777, within the nuclease domain (13). Muta-
tion of any of these cysteine residues impairs the nuclease
and ATPase activities of scDNA2. This suggests an essen-
tial role for the Fe–S cluster in substrate binding and/or
catalysis, as well as an interaction between scDNA2 nucle-
ase and helicase activities. Interestingly, biochemical anal-
ysis revealed that Cys to Ala mutations that impair these
activities do not affect substrate binding affinity but change
the substrate binding mode (13). Pokharel and Campbell
noticed that the replication-defective yeast strain dna2-1
harbors a P504S mutation, which is proximal to the Fe–S
cluster domain (13). The P504S mutation abolished the nu-
clease activity of scDNA2, caused temperature sensitivity,
and closely mimicked the global defects due to Fe–S clus-
ter mutations (13). Thus, it is likely that the conserved P504
residue is important in stabilizing the Fe–S cluster. The crys-
tal structure of mouse DNA2 bound to ssDNA revealed
that the Fe–S cluster is conserved in mammalian DNA2
(35). The structure also indicated that the Fe–S cluster sup-
ports the formation of the central tunnel for DNA substrate
binding and threading (35), explaining the observation that
mutations at the cluster domain alter the DNA substrate
binding mode.
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DNA2 IN HUMAN DISEASE
DNA2 as a tumor suppressor
Considering its importance in multiple DNA metabolic
pathways, DNA2 nuclease/helicase is crucial for maintain-
ing genome integrity. In mammalian cells, DNA2 is re-
quired to counteract various forms of DNA replication
stress; hence, DNA2 functional deficiency in mammalian
cells has been found to cause various forms of genome insta-
bility. It has long been hypothesized that cancer cells arise
and progress due to the accumulation of genetic and epige-
netic alterations (176). Consistent with this hypothesis, het-
erozygous Dna2 knockout mice have relatively high spon-
taneous cancer incidence compared to wild-type mice (75).
This result suggests that mammalian DNA2 functions as a
tumor suppressor by maintaining genome integrity.
One important function of mammalian DNA2 is to fa-
cilitate DNA replication at telomeres and centromeres, and
its dysfunction at these critical structures may promote
the development of cancer. In mouse cells, as originally
discovered in yeast (55), heterozygous knockout of the
Dna2 gene resulted in fragile telomeres, telomere shorten-
ing, and telomeric sister chromatid exchange (21). Dele-
tion of DNA2 genes in human HCT116 cells resulted in
incomplete DNA replication at centromeres, causing dys-
functional centromeres and chromosome segregation errors
that led to aneuploidy (77), a hallmark of many human
cancers that facilitates cancer development (177). Deple-
tion of DNA2 in human U2OS cells also resulted in the
incomplete DNA replication and an increase in the levels
of micronuclei and abnormal chromosomes (74). Further-
more, DNA2 deficiency in human cells results in defective
processing of stalled replication forks caused by exogenous
DNA insults, leading to the accumulation of DSBs, which
have been linked to chromosome deletions and transloca-
tions (126). In addition, in the absence of DNA2, alterna-
tive pathways are employed by cells to cleaveDNAflaps and
nascent DNA at stalled replication forks. These pathways
may release DNA fragments (178) that can be inserted at
DSB sites, which is a common occurrence in cancer. Indeed,
consistent with the enzymatic and cell biological studies de-
scribed above, Ira and colleagues have documented the role
of scDNA2 in limiting the insertion of retrotransposons or
other DNA fragments into DSBs (179). Additional studies
are required to determine if DNA2 is critical in suppressing
such genome-threatening events in mammalian cells.
DNA2 deficiency and DNA2 mutations have been linked
to human cancers, including gastric cancer (180). Goldberg
and colleagues investigated DNA2 mutations in estrogen-
relevant human cancers and reveal that 0.92%, 0.59% and
6.05% of ovarian, breast, and uterine cancers, respectively,
carry DNA2 mutations (181). Most of these somatic DNA2
mutations are missense mutations and are clustered in the
nuclease and helicase domains of DNA2 (181). To compre-
hensively define somatic DNA2 mutations in different hu-
man cancers, we surveyed a collection of 56 993 specimens
from 194 studies for DNA2 mutations using the cBiopor-
tal database (www.cBioportal.org) (182). We identified 280
loss-of-function (frame-shift or splicing) and missense mu-
tations in theDNA2 gene.DNA2mutations were frequent in
uterine carcinoma (40/529 or 7.56%), stomach carcinoma
(34/999 or 3.5%), bladder cancer (10/411 or 2.43%), and
melanoma (10/448 or 2.2%). On the other hand,DNA2mu-
tations were significantly less frequent in prostate cancer
(11/3647 or 0.3%), chronic lymphocytic leukemia (1/506 or
0.2%), clear cell renal cell carcinoma (1/502 or 0.2%), and
low grade glioma (1/514 or 0.19%). Most strikingly, the re-
currentDNA2 frame-shiftmutation S779fs*6 occurred in 18
stomach carcinomas, two uterine carcinomas, one adreno-
cortical carcinoma, and one colorectal carcinoma.Other re-
current mutations included loss-of-function and missense
mutations in the nuclease and helicase domains of DNA2.
The frequent occurrence of somaticDNA2mutations in hu-
man cancers is consistent with its role in genome stability
and tumor suppression. All these data support a role for
DNA2 in cancer etiology and indicate thatDNA2mutations
and functional deficiency may serve to promote cancer de-
velopment.
DNA2 as a promoter of cancer progression and potential anti-
cancer target
Although DNA2 is crucial for maintaining genome in-
tegrity and suppressing neoplastic transformation in nor-
mal mammalian cells, it has also been found to support can-
cer cell survival and progression by counteracting intrinsic
and external DNA replication stresses (23,75,183). DNA2
overexpression has been found in human cancers, including
breast and pancreatic cancers, and high levels of DNA2 ex-
pression have been associatedwith poor prognosis (23).Due
to the critical roles of DNA2 in DNA replication and DSB
repair, it has been proposed as an ideal target to sensitize
cancer cells to chemotherapy or radiotherapy treatment.
Most conventional chemotherapy agents target repli-
cation forks, including those that induce DNA lesions,
such as cisplatin, and those that stall forks, such as gem-
citabine and 5-fluorouracil (184). In addition, radiother-
apy, which is used to treat ∼50% of all cancers, kills
cancer cells by inducing DNA damage (185). Thus, in-
hibiting specific DNA replication and repair proteins like
DNA2 has been an attractive anti-cancer strategy. Com-
plete inactivation of either the DNA2 helicase or nucle-
ase is lethal to cells across species, from yeast to humans
(7,15,21,25,47,48,74,124,126). Furthermore, as discussed
above, DNA2mutations have been linked to cancers, as well
as developmental and mitochondrial disorders. However,
humans and mice heterozygous for DNA2 null mutations
are viable, due to partially compensating pathways, suggest-
ing that a therapeutic window can be found for DNA2 in-
hibition, particularly in cancers that overexpress DNA2.
DNA2 plays three key roles at DNA replication forks
to enable cancer cells to counteract intrinsic and exter-
nal DNA replication stresses induced by chemotherapy
or radiotherapy: 1) flap removal during DNA replica-
tion (11,32,34,46,54,107); 2) stabilization and resolution
of reversed forks (76,126,143); and 3) DNA end resection
(118,121,122,127,144). DNA2 also acts in signaling, as both
an activator and a target of checkpoint kinases. For exam-
ple, an N-terminal motif in scDNA2 is required to acti-
vate the yeast master signaling kinase MEC1/ATR (186).
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gkz1101/5637586 by C
alifornia Institute of Technology user on 25 N
ovem
ber 2019
14 Nucleic Acids Research, 2019
DNA2 is also a target of checkpoint effector kinases CHK1
and CHK2 and is required to regulate potentially deleteri-
ous fork reversal and template switching during replication
fork stalling in yeast and humans (143,187). Thus, inhibit-
ing DNA2 may simultaneously impair the ability of cancer
cells to handle DNA replication stress andDSBs, leading to
apoptosis and cellular senescence.
Supporting this hypothesis, recently developed small
molecule DNA2 inhibitors have been shown to kill and sen-
sitize cancer cells to ionizing radiation and camptothecin
(75,183). A joint effort by the Campbell and Shen groups
led to the identification of 4-hydroxy-8-nitroquinoline-3-
carboxylic acid (C5), via a high throughput virtual screen-
ing, as an effective and selective inhibitor of DNA2 (75).
C5 targets a DNA-binding motif in DNA2, blocking sub-
strate binding and inhibiting both its nuclease and helicase
activities. As a consequence, C5 inhibits DNA2-mediated
resection at stalled forks and at DSBs. C5 is an even more
potent inhibitor of stalled DNA replication fork restart and
of over-resection of nascent DNA in cells defective in repli-
cation fork protection, including those with mutations in
BRCA2, RAD51 and BOD1L. Notably, DNA2 inhibitors
also show cancer cell killing effects that are synergistic with
PARP inhibitors (75), which have excited the field as they
are synthetic lethal with BRCA1 and BRCA2 deficiencies
(188,189). Because PARP is also required to process some
Okazaki fragments (73), defects caused byDNA2 inhibitors
in either Okazaki fragment processing or HDR may con-
tribute to their synthetic lethality. The Sung, Ira and Peng
groups also worked together to screen scDNA2 inhibitors
using a fluorescence-based DNA2 nuclease activity assay
system (183). They found that compound NSC-105808 se-
lectively inhibits scDNA2 in vitro, as well as human DNA2
in vitro and in cells. Similar to C5, NSC-105808 reduced
DNA end resection and HDR efficiency and sensitized cells
to oncogene-induced replication stresses (183).
DNA2 in mitochondria-based diseases
The environment within mitochondria is known to be
highly oxidative. Thus, a robust BERmechanism is required
in mitochondria to repair base damage due to reactive ox-
idative species. The long-patch BER process is critical for
efficiently repairing base damage on mtDNA (190,191).
DNA2 can cleave nicks or short flaps with 5′ apurinic
groups and is required for BER in vitro (14). Thus, DNA2
gene deficiency causes cells to accumulate base damage on
mtDNA (14,162) and may lead to various mitochondria-
based diseases. A family-based whole genome DNA se-
quencing study detected theDNA2mutation R284H in two
siblings with muscle mitochondrial dysfunction but not in
their healthy brother (192). In the same study, a DNA2mu-
tation screening in 44 patients with mitochondrial myopa-
thy identified two carrying K313E and V723LDNA2muta-
tions, respectively. Biochemical analyses revealed that these
mutations altered the nuclease and helicase activities of
DNA2. Furthermore, DNA2mutant muscular tissues, sim-
ilar to Pol  andTwinklemutantmuscular tissues, displayed
multiple mtDNAdeletions (192,193). Another study identi-
fied a germlineDNA2 truncationmutation (Asn568Ilefs*4),
which eliminates the ATPase and helicase domains of hu-
man DNA2, in a patient who displayed congenital my-
opathy and ptosis (194). More recently, four additional
germlineDNA2mutations, A221G, S552L, S640L, R959H,
were identified in patients with myopathy (195). These mu-
tations significantly reduced the nuclease, ATPase, and heli-
case activities ofDNA2 in biochemical assays in vitro. These
findings suggest a role ofDNA2mutations in the pathogen-
esis of human mitochondrial disorders.
DNA2 in primordial dwarfism (PD)
In addition to mitochondrial myopathy and human cancer,
DNA2 has been implicated in PD. Patients with PD have
stunted growth, resulting in small adult body size, due to
severe impairments in fetal growth and postnatal develop-
ment (89,196). Seckel syndrome, a type of PD, has been
linked to abnormal centrosome assembly and DNA dam-
age responses (197). Autozygome-guided mutation analy-
sis detected a c.3372 + 6delC germline mutation shared by
two distant relatives within a family affected by PD (89).
The mutation causes DNA2 protein truncation and a re-
duction in its gene expression, thus leading to its func-
tional deficiency (89). In another study, whole exosome se-
quencing of 192 patients with microcephalic PD identified
variants in the DNA2 gene: two intronic variants (c.1764-
38 1764-37ins(53) and c.74+4A>C) and a missense variant
(c.1963A>G,T655A) (196). The authors demonstrated that
the two intronic variants alter DNA2 transcript splicing.
The T655A occurs at the conserved residue within the ATP
binding motif. These studies suggest that DNA2 is a PD
gene.
CONCLUDING REMARKS
DNA2 nuclease/helicase is a multifunctional enzyme that
plays critical roles in various DNA metabolic pathways, in-
cluding Okazaki fragment maturation, centromeric DNA
replication, maintenance of telomere stability, stalled repli-
cation fork processing, and HDR. The many, often redun-
dant activities of DNA2 have made it difficult to dissect its
precise molecular functions in each process. Though much
progress has beenmade, especially in understanding the role
of DNA2 in flap processing, we still do not understand why
the long-flap pathway evolved and whether it functions in
the removal of errors made by Pol /primase. The contri-
bution of DNA2 to Okazaki fragment processing in meta-
zoans also remains ripe for exploration. Future studies to
understand the functions and regulation of DNA2 in the
resection of DSBs, as well as its contributions to pathway
choice, checkpoint activation, and HDR, will require care-
ful, stepwise biochemical reconstitution experiments com-
bined with genetic approaches, similar to those applied to
investigate its contribution to lagging strand DNA repli-
cation. Future studies will also need to address the major
question of which types of lesions require which resection
pathways and how the multiple pathways are coordinated
and regulated. Answering these questions is also required
to delineate the mechanisms underlying the role of DNA2
at stalled DNA replication forks and in replication restart.
DNA2 also plays a direct role in protein-protein interac-
tions that induce the activity of the Mec1 kinase and the
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DNAdamage response in yeast.WhethermetazoanDNA2,
in addition to ATRIP and ETAA1, also performs this role
in either constitutive or exogenous DNA damage-induced
checkpoints has not been demonstrated.
Interestingly, DNA2 functions as both a tumor suppres-
sor and promoter. In normal cells, it works with other
genome stability genes to maintain the integrity of the
genome and to avoid neoplastic transformation. How-
ever, DNA2-mediated pathways that counteract replication
stresses and repair DSBs are also utilized to promote can-
cer cell survival. Therefore, although, like other current
chemotherapeutics, inhibitors of DNA2 may potentially
initiate new cancers, DNA2 has been suggested as a can-
cer therapeutic target. Given that many cancers are repair-
defective, whereas normal cells contain intact repair path-
ways, there is hope that a therapeutic windowmay be found
to kill cancers while sparing healthy tissues.
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